Explore the latest insights on clinical trial data and real-world evidence for innovative cancer therapies, highlighting ...
Hosted on MSN
Antibodies' decoy tactics for outmaneuvering pathogens could inspire next-generation treatments
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines of attack is to cling tenaciously to the surfaces of targeted human cells.
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...
Discover the innovative Alco5 platform by Tubulis, advancing cancer therapies with novel antibody-drug conjugate technology.
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines of attack is to cling tenaciously to the surfaces of targeted human cells.
HONG KONG, Nov. 7, 2024 /PRNewswire/ -- At the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024), held in Houston, USA, from November 6 - 10, Akeso Biopharma (9926. HK) ...
GOSSELIES, Belgium and NANTES, France, Nov. 12, 2025 /PRNewswire/ -- AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results